PARKER-HANNIFIN CORPORATION Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2017-02-21: Study NCT03054064; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2016-06: Study NCT02793635; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2015-05: Study NCT02341287; Company role Collaborator; Phase Not applicable; Status Terminated.
- 2014-08: Study NCT02202538; Company role Lead sponsor; Phase Not applicable; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2017-02-21 | NCT03054064 Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA | Lead sponsor | Not applicable | Completed Results posted | Cerebrovascular Accident (CVA); Stroke; Hemiplegia | 48 | 2018-01-17 |
| 2016-06 | NCT02793635 Indego Exoskeleton After SCI | Lead sponsor | Not applicable | Completed | Spinal Cord Injury | 9 | 2018-03 |
| 2015-05 | NCT02341287 Temperature Manipulating Gloves for the Treatment of Insomnia | Collaborator Lead: Weill Medical College of Cornell University | Not applicable | Terminated Results posted | Insomnia | 13 | 2016-04-07 |
| 2014-08 | NCT02202538 Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI). | Lead sponsor | Not applicable | Completed Results posted | Spinal Cord Injury | 53 | 2015-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Crane Co (CR) | United States | $11.818B | 38.39 |
| Mueller Water Products, Inc. (MWA) | United States | $3.350B | 18.15 |
| Crane NXT, Co. (CXT) | United States | $2.717B | 20.98 |
| HELIOS TECHNOLOGIES, INC. (HLIO) | United States | $2.252B | 38.08 |
| Elmet Group Co. (ELMT) | United States | $0.601B | |
| AMERICAN REBEL HOLDINGS INC (AREB) | United States | $0.004B |